{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:49:09Z","timestamp":1791823749900,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Poor responders pose a significant challenge in fertility treatment, leading to decreased oocyte quality and fertilization rates. Assisted oocyte activation (AOA) has emerged as a method to improve fertilization rates. This study aims to evaluate the effect of AOA on fertilization, pregnancy, and live birth rates in patients with diminished ovarian reserve.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This prospective non-randomized comparative study included a cohort of infertility patients with diminished ovarian reserve, divided into three groups: the control group receiving standard treatment (Group I\/Conventional ICSI), the electrical activation group undergoing piezoelectric stimulation (Group II\/ICSI\u2009+\u2009Piezoelectric), and the chemical activation group treated with calcium ionophore (Group III\/ICSI\u2009+\u2009Calcium Ionophore). Each group consisted of 50 patients. The effects of electrical and chemical activation applied after ICSI on fertilization, pregnancy, and live birth rates were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were no statistically significant differences among the groups in hormone levels (FSH, LH, E2, PRL, and AMH), number of oocytes, or number of MII oocytes. Fertilization rates were significantly higher in the piezoelectric group compared to the control group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007). Although the fertilization rate in the calcium ionophore group was higher than that in the control group, this difference did not reach statistical significance (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20091.000). There was no statistically significant difference in fertilization rates between the piezoelectric and calcium ionophore groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.071). Regarding pregnancy rates, the highest implantation rate was observed in the calcium ionophore group (37%), but this difference does not reach statistical significance (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.224). No significant differences were observed among the groups in embryo quality, clinical pregnancy, ongoing pregnancy, and live birth rates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients classified as diminished ovarian reserve, artificial oocyte activation (AOA) was associated with higher fertilization rates for increasing fertilization rates, potentially resulting in a greater number of fertilized oocytes and transferable embryos. However, this apparent benefit does not translate into improved biochemical pregnancy outcomes. Moreover, no significant differences were observed between groups in terms of embryo quality, clinical pregnancy, ongoing pregnancy, and live birth rates. These findings suggest that while AOA may enhance early laboratory outcomes, its impact on clinically meaningful reproductive endpoints remains limited. Therefore, further adequately powered randomized studies are required to clarify the efficacy and safety of AOA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00404-026-08491-3","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:56:39Z","timestamp":1784217399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is assisted oocyte activation an effective method in poor responders?"],"prefix":"10.1007","volume":"313","author":[{"given":"Ay\u015fe","family":"Altun Akpinar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-4502","authenticated-orcid":false,"given":"Bur\u00e7in","family":"Karamustafao\u011flu Balc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7i\u011fdem","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemil","family":"Akg\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"11","key":"8491_CR1","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1093\/humrep\/dead021","volume":"38","author":"European Society of Human Reproduction and Embryology","year":"2023","unstructured":"European Society of Human Reproduction and Embryology (2023) ESHRE good practice recommendations on add-ons. Human Reprod 38(11):2062\u20132104. https:\/\/doi.org\/10.1093\/humrep\/dead021","journal-title":"Human Reprod"},{"issue":"1","key":"8491_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/humupd\/dmg007","volume":"9","author":"BC Tarlatzis","year":"2003","unstructured":"Tarlatzis BC, Zepiridis GGF, Bontis J (2003) Clinical management of low ovarian response to stimulation for IVF: a systematic review. Human Reprod Updaten 9(1):61\u201376. https:\/\/doi.org\/10.1093\/humupd\/dmg007","journal-title":"Human Reprod Updaten"},{"issue":"4","key":"8491_CR3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1472-6483(10)62164-5","volume":"6","author":"U Ulug","year":"2003","unstructured":"Ulug U, Ben-Shlomo I, Turan E, Erden HF, Akman MA, Bahceci M (2003) Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles. Reprod Biomed Online 6(4):439\u2013443. https:\/\/doi.org\/10.1016\/S1472-6483(10)62164-5","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"8491_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.24074\/tjrms.2022-88104","volume":"5","author":"R Pabuccu","year":"2021","unstructured":"Pabuccu R, Pabuccu EG, Kanat AO (2021) Investigation of the effects of oocyte activation with calcium ionophore on embryogenesis and clinical outcomes in patients with severe oligoasthenoteratozoospermia. Turk J Reprod Med Surg 5(3):102\u2013108. https:\/\/doi.org\/10.24074\/tjrms.2022-88104","journal-title":"Turk J Reprod Med Surg"},{"key":"8491_CR5","doi-asserted-by":"publisher","first-page":"1244507","DOI":"10.3389\/fendo.2023.1244507","volume":"14","author":"JL Ruan","year":"2023","unstructured":"Ruan JL, Liang SS, Pan JP, Chen ZQ, Teng XM (2023) Artificial oocyte activation with Ca2\u207a ionophore improves reproductive outcomes in patients with fertilization failure and poor embryo development in previous ICSI cycles. Front Endocrinol 14:1244507. https:\/\/doi.org\/10.3389\/fendo.2023.1244507","journal-title":"Front Endocrinol"},{"issue":"1","key":"8491_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10815-024-03319-y","volume":"42","author":"J Zhang","year":"2025","unstructured":"Zhang J, Sui Y, Xiao M, Sun X, Fu J (2025) Assessing the impact of calcium ionophore on pregnancy outcomes in artificial oocyte activation cycles: a 10 year update of systematic review and meta-analysis. J Assist Reprod Genet 42(1):165\u2013183. https:\/\/doi.org\/10.1007\/s10815-024-03319-y","journal-title":"J Assist Reprod Genet"},{"issue":"Suppl 1","key":"8491_CR7","doi-asserted-by":"publisher","first-page":"deae108.485","DOI":"10.1093\/humrep\/deae108.485","volume":"39","author":"R Huseynli","year":"2024","unstructured":"Huseynli R, Tulumbaci OP (2024) Artificial oocyte activation (AOA) via piezoelectric stimulation after intracytoplasmic sperm injection (ICSI) in patients with teratozoospermia. Hum Reprod 39(Suppl 1):deae108.485. https:\/\/doi.org\/10.1093\/humrep\/deae108.485","journal-title":"Hum Reprod"},{"issue":"2","key":"8491_CR8","doi-asserted-by":"publisher","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa067","volume":"1","author":"E Bosch","year":"2020","unstructured":"Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E et al (2020) European society of human reproduction and embryology (ESHRE) guideline on ovarian stimulation for IVF\/ICSI. Hum Reprod Open 1(2):hoaa009. https:\/\/doi.org\/10.1093\/hropen\/hoaa067","journal-title":"Hum Reprod Open"},{"key":"8491_CR9","volume-title":"WHO laboratory manual for the examination and processing of human semen","author":"World Health Organization","year":"2021","unstructured":"World Health Organization (2021) WHO laboratory manual for the examination and processing of human semen, 6th edn. World Health Organization, Geneva","edition":"6"},{"issue":"4","key":"8491_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.rbmo.2014.11.006","volume":"30","author":"T Ebner","year":"2015","unstructured":"Ebner T, Montag M (2015) Oocyte activation study group. Live birth after artificial oocyte activation using a ready-to-use calcium ionophore solution. Reprod BioMed Online 30(4):359\u2013365. https:\/\/doi.org\/10.1016\/j.rbmo.2014.11.006","journal-title":"Reprod BioMed Online"},{"issue":"6","key":"8491_CR11","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/humrep\/der037","volume":"26","author":"Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology","year":"2011","unstructured":"Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology (2011) The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod 26(6):1270\u20131283. https:\/\/doi.org\/10.1093\/humrep\/der037","journal-title":"Hum Reprod"},{"key":"8491_CR12","first-page":"378","volume-title":"Towards Reproductive Certainty: Fertility and Genetics Beyond","author":"DK Gardner","year":"1999","unstructured":"Gardner DK (1999) Schoolcraft WB (1999) In vitro culture of human blastocysts. In: Jansen R, Mortimer D (eds) Towards Reproductive Certainty: Fertility and Genetics Beyond. Parthenon Press, Carnforth, pp 378\u2013388"},{"issue":"2","key":"8491_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/rmb2.12324","volume":"19","author":"Y Fujii","year":"2020","unstructured":"Fujii Y, Endo Y, Mitsuhata S, Hayashi M, Motoyama H (2020) Evaluation of the effect of piezo-intracytoplasmic sperm injection on the laboratory, clinical, and neonatal outcomes. Reprod Med Biol 19(2):198\u2013205. https:\/\/doi.org\/10.1002\/rmb2.12324","journal-title":"Reprod Med Biol"},{"issue":"4","key":"8491_CR14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/rmb2.12290","volume":"18","author":"K Furuhashi","year":"2019","unstructured":"Furuhashi K, Saeki Y, Enatsu N, Iwasaki T, Ito K, Mizusawa Y et al (2019) Piezo-assisted ICSI improves fertilization and blastocyst development rates compared with conventional ICSI in women aged more than 35 years. Reprod Med Biol 18(4):357\u2013361. https:\/\/doi.org\/10.1002\/rmb2.12290","journal-title":"Reprod Med Biol"},{"issue":"3","key":"8491_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.rbmo.2021.05.020","volume":"43","author":"D Zander-Fox","year":"2021","unstructured":"Zander-Fox D, Lam K, Pacella-Ince L, Tully C, Hamilton H, Hiraoka K et al (2021) PIEZO-ICSI increases fertilization rates compared with standard ICSI: a prospective cohort study. Reprod Biomed Online 43(3):404\u2013412. https:\/\/doi.org\/10.1016\/j.rbmo.2021.05.020","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"8491_CR16","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.12688\/f1000research.10382.1","volume":"23","author":"P Humaidan","year":"2016","unstructured":"Humaidan P, Alviggi C, Fischer R, Esteves SC (2016) The novel POSEIDON stratification of \u201clow prognosis patients in ART\u201d and its proposed marker of successful outcome. F1000Research 23(5):2911. https:\/\/doi.org\/10.12688\/f1000research.10382.1","journal-title":"F1000Research"},{"issue":"4","key":"8491_CR17","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.rbmo.2021.06.004","volume":"42","author":"KWK Lam","year":"2021","unstructured":"Lam KWK, Li RHW, Lau EY, Chan PK, Lee WM (2021) Artificial oocyte activation to improve reproductive outcomes in couples with various causes of infertility: a retrospective cohort study. Reprod Biomed Online 42(4):648\u2013653. https:\/\/doi.org\/10.1016\/j.rbmo.2021.06.004","journal-title":"Reprod Biomed Online"},{"issue":"8","key":"8491_CR18","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/humrep\/dev136","volume":"30","author":"IA Sfontouris","year":"2015","unstructured":"Sfontouris IA, Nastri CO, Lima ML, Tahmasbpourmarzouni E, Raine-Fenning N, Martins WP (2015) Artificial oocyte activation to improve reproductive outcomes in women with previous fertilization failure: a systematic review and meta-analysis of RCTs. Hum Reprod 30(8):1831\u20131841. https:\/\/doi.org\/10.1093\/humrep\/dev136","journal-title":"Hum Reprod"},{"issue":"1","key":"8491_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2161-0436.1000122","volume":"4","author":"V Baltac\u0131","year":"2014","unstructured":"Baltac\u0131 V, Aktas Y, Unsal E, Ayvaz O, Turhan F, S\u0131nano\u011flu B et al (2014) The effect of piezoelectric stimulation in patients with low fertilization potential. Human Genet Embryol 4(1):1\u20135. https:\/\/doi.org\/10.4172\/2161-0436.1000122","journal-title":"Human Genet Embryol"},{"issue":"3 Suppl","key":"8491_CR20","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1016\/j.fertnstert.2015.07.963","volume":"104","author":"SC Aytac","year":"2015","unstructured":"Aytac SC, Sahin G, Satiroglu H (2015) Artificial oocyte activation with calcium ionophore in poor ovarian response patients undergoing ICSI. Fertil Steril 104(3 Suppl):e314. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.07.963","journal-title":"Fertil Steril"},{"issue":"1","key":"8491_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.fertnstert.2007.08.017","volume":"91","author":"R Mansour","year":"2009","unstructured":"Mansour R, Fahmy I, Tawab NA, Kamal A, El-Demery Y, Aboulghar M et al (2009) Electrical activation of oocytes after intracytoplasmic sperm injection: a controlled randomized study. Fertil Steril 91(1):133\u2013139. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.08.017","journal-title":"Fertil Steril"},{"issue":"9","key":"8491_CR22","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3390\/cimb47090707","volume":"47","author":"S Azil","year":"2025","unstructured":"Azil S, Kaarouch I, Montjean D, Pag\u00e9 MHG, Cabry R, Louanjli N (2025) Effect of sperm DNA fragmentation and chromatin decondensation on PLC\u03b6 efficacy in infertile patients. Curr Issues Mol Biol 47(9):707. https:\/\/doi.org\/10.3390\/cimb47090707","journal-title":"Curr Issues Mol Biol"},{"key":"8491_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoac003","author":"J Kashir","year":"2022","unstructured":"Kashir J, Nomikos M, Lai FA (2022) Oocyte activation deficiency and assisted oocyte activation: mechanisms, obstacles and prospects for clinical application. Hum Reprod Open. https:\/\/doi.org\/10.1093\/hropen\/hoac003","journal-title":"Hum Reprod Open"},{"issue":"1","key":"8491_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.18502\/jfrh.v17i1.11977","volume":"17","author":"B Kaur","year":"2023","unstructured":"Kaur B, Malik S, Prakash V, Bhatia V, Gupta D (2023) Efficacy of artificial oocyte activation in improving the reproductive outcome in poor responders: a single centre cohort study. J Fam Reprod Health 17(1):45\u201353. https:\/\/doi.org\/10.18502\/jfrh.v17i1.11977","journal-title":"J Fam Reprod Health"},{"issue":"1","key":"8491_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-022-01036-7","volume":"15","author":"TE Tsai","year":"2022","unstructured":"Tsai TE, Lin PH, Lian PF, Li CJ, Vitale SG, Miku\u0161 M et al (2022) Artificial oocyte activation may improve embryo quality in older patients with diminished ovarian reserve undergoing IVF-ICSI cycles. J Ovarian Res 15(1):102. https:\/\/doi.org\/10.1186\/s13048-022-01036-7","journal-title":"J Ovarian Res"},{"key":"8491_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.07.1134","author":"T Ebner","year":"2012","unstructured":"Ebner T, K\u00f6ster M, Shebl O, Moser M (2012) Application of a ready-to-use calcium ionophore increases rates of fertilization and pregnancy in severe male factor infertility. Fertil Steril. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.07.1134","journal-title":"Fertil Steril"},{"issue":"11","key":"8491_CR27","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1093\/humrep\/dead220","volume":"38","author":"S Norcross","year":"2023","unstructured":"Norcross S, Zanders M, Dancet EAF, Le Clef N, Vermeulen N, Lundin K (2023) Good practice recommendations on add-ons in reproductive medicine. ESHREHuman Reprod 38(11):2062\u20132107. https:\/\/doi.org\/10.1093\/humrep\/dead220","journal-title":"ESHREHuman Reprod"},{"issue":"3","key":"8491_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.fertnstert.2015.11.017","volume":"105","author":"A Capalbo","year":"2016","unstructured":"Capalbo A, Ottolini CS, Griffin DK, Ubaldi FM, Handyside AH, Rienzi L (2016) Artificial oocyte activation with calcium ionophore does not cause a widespread increase in chromosome segregation errors in the second meiotic division of the oocyte. Fertil Steril 105(3):807-814.e2. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.11.017","journal-title":"Fertil Steril"},{"issue":"5","key":"8491_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.rbmo.2013.10.020","volume":"28","author":"S VandenMeerschaut","year":"2014","unstructured":"VandenMeerschaut S, Nikiforaki D, Heindryckx B, De Gheselle S, Dullaerts V, Van den Abbeel E et al (2014) Assisted oocyte activation is not associated with an increased risk of congenital birth defects in human offspring. Reprod BioMed Online 28(5):553\u2013557. https:\/\/doi.org\/10.1016\/j.rbmo.2013.10.020","journal-title":"Reprod BioMed Online"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-026-08491-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08491-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08491-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:06:06Z","timestamp":1791821166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-026-08491-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8491"],"URL":"https:\/\/doi.org\/10.1007\/s00404-026-08491-3","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent prepared based on ethical approval was obtained from patients.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":3,"name":"Ethics","label":"Registry and the registration no. of the study\/trial","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":4,"name":"Ethics","label":"Animal studies","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"289"}}